Literature DB >> 11432420

Mechanisms of quinolone resistance in Salmonella.

A Cloeckaert1, E Chaslus-Dancla.   

Abstract

As in other Gram-negative bacteria, mechanisms of resistance to quinolones in Salmonella include target gene mutations, active efflux, and decreased outer membrane permeability. However, the exact contribution of these individual mechanisms to resistance, which may nevertheless interplay to reach high-level resistance, has not yet clearly been defined as in other bacteria such as Escherichia coli. This paper reviews the current state of knowledge of quinolone resistance mechanisms in Salmonella by comparison with that of E. coli and future directions of research with particular attention to the recent development of efflux pump inhibitors as possible means of avoiding the emergence and spread of fluoroquinolone resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432420     DOI: 10.1051/vetres:2001105

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  26 in total

1.  Specific gyrA mutation at codon 83 in nalidixic acid-resistant Salmonella enterica serovar Typhi strains isolated from Vietnamese patients.

Authors:  Le Van Phung; Haruko Ryo; Taisei Nomura
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Molecular modeling and active site analysis of SdiA homolog, a putative quorum sensor for Salmonella typhimurium pathogenecity reveals specific binding patterns of AHL transcriptional regulators.

Authors:  Shanmugam Gnanendra; Shanmugam Anusuya; Jeyakumar Natarajan
Journal:  J Mol Model       Date:  2012-06-02       Impact factor: 1.810

3.  Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany.

Authors:  Beatriz Guerra; Burkhard Malorny; Andreas Schroeter; Reiner Helmuth
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

5.  Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.

Authors:  Anne Olliver; Michel Vallé; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  GyrA ser83 and ParC trp106 Mutations in Salmonella enterica Serovar Typhi Isolated from Typhoid Fever Patients in Tertiary Care Hospital.

Authors:  Muthu Gopal; Sathishkumar Elumalai; Suresh Arumugam; Vishnuprabu Durairajpandian; Munirajan Arasambattu Kannan; Esthermary Selvam; Srivani Seetharaman
Journal:  J Clin Diagn Res       Date:  2016-07-01

7.  Long-term dissemination of CTX-M-5-producing hypermutable Salmonella enterica serovar typhimurium sequence type 328 strains in Russia, Belarus, and Kazakhstan.

Authors:  Varvara K Kozyreva; Elena N Ilina; Maja V Malakhova; Alessandra Carattoli; Ilya S Azizov; Dmitry V Tapalski; Roman S Kozlov; Mikhail V Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

8.  AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.

Authors:  Sylvie Baucheron; Shaun Tyler; David Boyd; Michael R Mulvey; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type.

Authors:  B Preethi; K Ramanathan
Journal:  Eur Biophys J       Date:  2015-09-02       Impact factor: 1.733

10.  ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.

Authors:  Yousef M Abouzeed; Sylvie Baucheron; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.